Propavan: Uses, Dosage & Side Effects
A phenothiazine-derivative sedative for short-term treatment of sleep disorders in adults
Quick Facts About Propavan
Key Takeaways About Propavan
- Non-benzodiazepine sleep aid: Propavan works by blocking histamine H1 receptors in the brain, offering a different mechanism from benzodiazepines and Z-drugs with lower dependence risk
- Takes 1–2 hours for full effect: Take Propavan 30 to 60 minutes before bedtime; it provides sustained sleep throughout the night
- Short-term use only: Propavan is intended for short-term treatment of insomnia; prolonged use should be avoided
- Caution in elderly: Older adults may be more sensitive to side effects including daytime drowsiness, muscle stiffness, and restlessness
- Do not combine with alcohol: Alcohol combined with Propavan can cause extreme drowsiness and loss of consciousness, which can be life-threatening
What Is Propavan and What Is It Used For?
Propavan is a prescription sedative-hypnotic medication containing propiomazine, a phenothiazine derivative that dampens activity in certain regions of the brain to promote sleep. It is prescribed for the short-term treatment of various forms of sleep disturbance in adults and reaches full effect within 1 to 2 hours.
Propavan belongs to the phenothiazine class of medications, a group of compounds originally developed as antipsychotic agents. Propiomazine, the active ingredient in Propavan, is used at lower doses specifically for its sedative and sleep-promoting properties. Unlike benzodiazepines (such as diazepam) and Z-drugs (such as zopiclone), propiomazine does not act on the gamma-aminobutyric acid (GABA) receptor system. Instead, it primarily blocks histamine H1 receptors in the central nervous system, which produces sedation. It also has weak dopamine D2 receptor antagonist activity, which accounts for some of its neurological side effects at higher doses or with prolonged use.
Propavan is indicated for the short-term management of insomnia in adults, including difficulty falling asleep, frequent nighttime awakenings, and early morning waking. The medication has a relatively long onset of action — full effect is typically reached 1 to 2 hours after oral administration — but provides sustained sedation throughout the night, which helps reduce the total number of awakenings. This pharmacokinetic profile makes Propavan particularly useful for patients who experience sleep maintenance difficulties rather than purely sleep-onset problems.
The half-life of propiomazine is approximately 8 to 10 hours, meaning the drug remains active in the body for a considerable period. While this sustained action is beneficial for maintaining sleep, it also means that residual drowsiness may be present the following morning, particularly in elderly patients or those with impaired liver function. Patients should be made aware that their alertness, reaction time, and ability to drive or operate machinery may be impaired the morning after taking Propavan.
It is important to recognise that Propavan, like all hypnotic medications, treats the symptom of insomnia rather than its underlying cause. Before prescribing Propavan, healthcare providers should investigate contributing factors such as anxiety, depression, chronic pain, sleep apnoea, or poor sleep hygiene. Non-pharmacological interventions — including cognitive behavioural therapy for insomnia (CBT-I), sleep hygiene education, and relaxation techniques — are recommended by international guidelines as first-line treatments for chronic insomnia before hypnotic medication is considered.
Propavan (propiomazine) is primarily available in Scandinavian countries and is not widely marketed internationally. In other regions, healthcare providers may prescribe alternative sedatives with similar mechanisms, such as promethazine or hydroxyzine, both of which are antihistamine-based sleep aids. While these medications share some pharmacological properties with propiomazine, they are not identical and doses are not interchangeable. Always follow your prescriber's guidance regarding which medication is appropriate for your situation.
What Should You Know Before Taking Propavan?
Propavan is not suitable for everyone. You must not take Propavan if you are allergic to propiomazine or any of its inactive ingredients. Patients with liver or kidney impairment, a history of substance misuse, or chronic insomnia due to underlying medical conditions should use Propavan with particular caution.
Contraindications
You must not take Propavan if any of the following applies to you:
- Allergy to propiomazine or any of the other ingredients in the tablet (see the Composition section for a full list of inactive ingredients)
- Known hypersensitivity to phenothiazine compounds: Cross-reactivity between different phenothiazine derivatives is possible, so patients with a history of allergic reactions to any phenothiazine should avoid Propavan
Warnings and Precautions
Talk to your healthcare provider before taking Propavan if you have any of the following conditions or risk factors:
- Reduced liver function: Propiomazine is metabolised in the liver. Impaired hepatic function can lead to higher blood levels of the drug and an increased risk of side effects. Your dose may need to be reduced.
- Reduced kidney function: Although propiomazine is not primarily excreted by the kidneys, renal impairment can affect the clearance of metabolites. Dose adjustment may be required.
- Chronic or prolonged insomnia: If your sleep difficulties have persisted for a long time, they may be caused by an underlying physical or psychological condition that requires specific treatment rather than symptomatic relief with a hypnotic medication.
- History of substance misuse: Patients with a current or past history of alcohol, drug, or medication misuse should use Propavan only under close medical supervision, as there is a risk of psychological dependence.
Prolonged use of Propavan can cause dry mouth (xerostomia), which significantly increases the risk of tooth decay and damage to the oral mucosa. If you are taking Propavan for more than a few days, maintain thorough oral hygiene: brush your teeth carefully with fluoride toothpaste twice daily, use sugar-free chewing gum or lozenges to stimulate saliva production, and stay well hydrated. Report persistent dry mouth to your healthcare provider.
Propavan should be used with particular caution in older adults, as they may be more sensitive to the effects of propiomazine. Elderly patients are at increased risk of experiencing daytime drowsiness, muscle stiffness (rigidity), slowed movement (bradykinesia), restlessness or agitation (akathisia), and increased fall risk. The lowest effective dose should be used for the shortest possible duration, and patients should be regularly reassessed.
Pregnancy and Breastfeeding
If you are pregnant, think you may be pregnant, plan to become pregnant, or are breastfeeding, seek advice from your healthcare provider before taking Propavan.
Pregnancy: Propavan is not recommended during pregnancy. There is insufficient data on the use of propiomazine in pregnant women, and the potential risks to the developing foetus have not been adequately studied. Your healthcare provider will weigh the benefits and risks before prescribing Propavan to a pregnant woman and will usually recommend non-pharmacological alternatives for managing insomnia during pregnancy.
Breastfeeding: It is currently unknown whether propiomazine passes into human breast milk. The benefit of treatment for the mother must be weighed against the potential risks to the nursing infant. If treatment with Propavan is deemed necessary, your healthcare provider may advise on alternative feeding arrangements during the treatment period. Discuss your options with your doctor.
Driving and Operating Machinery
Propavan can cause drowsiness and dizziness, which may impair your reaction time and your ability to drive or operate machinery safely. These effects can persist into the morning following an evening dose, particularly in the initial days of treatment or when the dose is increased. You are personally responsible for assessing whether you are fit to drive or perform precision work. Do not drive, cycle, or operate dangerous machinery until you know how Propavan affects you.
Propavan tablets contain anhydrous lactose (116 mg per tablet). If you have been told by your doctor that you have an intolerance to certain sugars, contact your healthcare provider before taking this medicine.
How Does Propavan Interact with Other Drugs?
Propavan interacts with many medications, particularly those that affect the central nervous system. The most dangerous interactions are with antipsychotics, opioids, benzodiazepines, barbiturates, and alcohol, which can cause extreme drowsiness and loss of consciousness that can be life-threatening. Always inform your doctor about all medications you are taking.
Propiomazine has a sedative mechanism that can be potentiated by any substance that depresses the central nervous system. When Propavan is combined with other CNS depressants, the risk of profound sedation, respiratory depression, and loss of consciousness increases significantly. Additionally, propiomazine's phenothiazine structure means it may interact with medications that affect dopaminergic pathways or that are metabolised by the same hepatic enzymes.
Major Interactions
The following drug combinations with Propavan carry significant clinical risk and should generally be avoided or used only under close medical supervision:
| Drug / Drug Class | Effect | Clinical Significance |
|---|---|---|
| Opioid analgesics (morphine, codeine, tramadol, oxycodone, fentanyl) | Additive CNS depression; risk of extreme drowsiness, respiratory depression, coma | Potentially life-threatening. Combined use only when no alternatives exist. Doses and duration should be minimised. |
| Benzodiazepines (diazepam, lorazepam, alprazolam) | Enhanced sedation, respiratory depression, increased fall risk, potential loss of consciousness | High risk. Concurrent use should be avoided. If necessary, use lowest effective doses for shortest duration. |
| Alcohol | Extreme drowsiness, loss of consciousness, respiratory depression | Must be avoided. Combined use can be life-threatening. |
| Antipsychotics / neuroleptics (haloperidol, quetiapine, olanzapine) | Additive CNS depression, increased risk of extrapyramidal side effects, hypotension | Avoid combination where possible. Risk of severe neurological side effects is significantly increased. |
| Barbiturates (phenobarbital) | Profound sedation, respiratory depression | Avoid concurrent use. The sedative effects are synergistic and potentially dangerous. |
Moderate Interactions
The following interactions may require dose adjustments or careful monitoring:
| Drug / Drug Class | Effect | Clinical Significance |
|---|---|---|
| Other sleep medications (zopiclone, zolpidem, melatonin) | Additive sedation, increased risk of next-day drowsiness | Avoid concurrent use. Using multiple sleep medications simultaneously offers no additional benefit and increases risk. |
| Sedating antihistamines (promethazine, hydroxyzine, diphenhydramine) | Additive sedation and anticholinergic effects (dry mouth, constipation, urinary retention) | Avoid combining. Both drug classes block H1 receptors, leading to excessive sedation. |
| Sedating antidepressants (mirtazapine, amitriptyline, trazodone) | Enhanced sedation, increased anticholinergic burden | Monitor for excessive drowsiness. Dose reduction of one or both drugs may be necessary. |
| Muscle relaxants (baclofen, tizanidine) | Additive CNS depression and muscle relaxation | Use with caution. Monitor for excessive sedation and impaired motor function. |
| Antihypertensives (beta-blockers, ACE inhibitors) | Propiomazine may enhance hypotensive effects | Monitor blood pressure, particularly when standing. Risk of orthostatic hypotension. |
What Is the Correct Dosage of Propavan?
The recommended adult dose of Propavan is 25 to 50 mg (1 to 2 tablets) taken 30 to 60 minutes before bedtime. The dose is determined individually by your healthcare provider. The lowest effective dose should be used for the shortest possible treatment duration. Do not exceed the recommended dose.
Always use Propavan exactly as prescribed by your healthcare provider. The dose and treatment duration are individualised based on the severity of your insomnia, your age, and any other medical conditions you may have. Do not change your dose without consulting your prescriber.
Adults (18–64 years)
Standard Adult Dose
Recommended dose: 1 to 2 tablets (25–50 mg) taken 30 to 60 minutes before bedtime.
Maximum dose: 50 mg (2 tablets) per day. Do not exceed this dose.
Duration: Treatment should be as short as possible. The prescriber should reassess the need for continued treatment regularly.
Note: The score line on the tablet is for ease of swallowing only (to allow halving the tablet) and does not indicate a half-dose.
Elderly Patients (65 years and over)
Elderly Dose
Starting dose: 25 mg (1 tablet) at bedtime. The lowest effective dose should be used.
Considerations: Elderly patients are more susceptible to the effects of propiomazine, including daytime drowsiness, muscle stiffness, and postural instability. Careful monitoring for adverse effects is essential, and the dose should be increased only if absolutely necessary.
Children and Adolescents
Paediatric Use
Propavan is indicated for use in adults only. It is not recommended for children or adolescents under 18 years of age. Safety and efficacy in the paediatric population have not been established.
| Patient Group | Starting Dose | Maximum Dose | Timing |
|---|---|---|---|
| Adults (18–64 years) | 25–50 mg | 50 mg/day | 30–60 min before bed |
| Elderly (≥65 years) | 25 mg | 50 mg/day | 30–60 min before bed |
| Liver impairment | 25 mg (with caution) | Individualised | 30–60 min before bed |
| Kidney impairment | 25 mg (with caution) | Individualised | 30–60 min before bed |
| Children (<18 years) | Not recommended | N/A | N/A |
Missed Dose
Do not take a double dose to make up for a forgotten dose. If you remember your missed dose and still have enough time for a full night's sleep, take it immediately. If morning is approaching and you do not have enough time for adequate rest, skip the missed dose and take your next dose at the usual time the following evening. Taking Propavan too close to the time you need to wake up may result in excessive morning drowsiness.
Overdose
If you or someone else has taken too much Propavan, contact your local emergency services or poison control centre immediately. Propavan overdose can be life-threatening, especially when combined with alcohol, recreational drugs, or other medications that depress the central nervous system.
Symptoms of Propavan overdose may include: excessive drowsiness, confusion, loss of consciousness, restlessness, hallucinations, seizures (convulsions), dilated pupils, rapid heartbeat (tachycardia), irregular pulse, low blood pressure (hypotension), breathing difficulties, and abnormally elevated body temperature (hyperthermia). Emergency medical treatment may include supportive care, airway management, and monitoring in a hospital intensive care setting.
What Are the Side Effects of Propavan?
The most common side effect of Propavan is drowsiness, which may persist into the following day. Rare but notable side effects include dry mouth, allergic skin reactions, dizziness, low blood pressure, and movement disorders such as muscle stiffness and restless legs. Contact your healthcare provider if side effects are persistent or troublesome.
Like all medicines, Propavan can cause side effects, although not everyone will experience them. Most side effects are dose-related and tend to be more pronounced in elderly patients or those taking higher doses. If you experience any unexpected symptoms while taking Propavan, consult your healthcare provider.
Common Side Effects
- Drowsiness (somnolence) – the most frequently reported side effect; may persist into the morning after taking the medication, particularly in elderly patients or at higher doses
Rare Side Effects
- Dry mouth (xerostomia) – prolonged dryness can increase the risk of dental caries and oral mucosal damage
- Allergic skin reactions – rash, itching, or photosensitivity (skin rash triggered by exposure to sunlight)
- Dizziness (vertigo)
- Low blood pressure (hypotension) – may cause lightheadedness, particularly when standing up quickly
- Decreased platelet count (thrombocytopenia) – may increase the risk of bruising or bleeding
- Muscle stiffness (rigidity) and slowed movement (bradykinesia) – extrapyramidal symptoms related to dopamine receptor blockade
- Involuntary muscle movements (dyskinesia) – including facial tics or other abnormal movements
- Restless legs syndrome – an uncomfortable urge to move the legs, particularly at rest
- Tingling, numbness, or tremors (paraesthesia, tremor) – neurological symptoms that should be reported to your doctor
If you experience any side effects that are severe, persistent, or worrying, contact your healthcare provider. You should also report any suspected side effects to your national pharmacovigilance authority to help with ongoing safety monitoring of the medication.
Because propiomazine is a phenothiazine derivative with weak dopamine D2 receptor blocking activity, it can occasionally cause movement-related side effects known as extrapyramidal symptoms (EPS). These may include muscle stiffness, tremor, restlessness, and involuntary movements. EPS are more common in elderly patients and with prolonged use. If you develop any unusual muscle stiffness, involuntary movements, or persistent restlessness, inform your healthcare provider promptly, as dose adjustment or treatment discontinuation may be necessary.
How Should You Store Propavan?
Store Propavan at room temperature in its original packaging. No special storage conditions are required. Keep the medication out of the sight and reach of children. Do not use after the expiry date.
Proper storage of Propavan is important to maintain its effectiveness and safety:
- Temperature: No special storage temperature requirements. Store at normal room temperature.
- Original packaging: Keep the tablets in their original blister packaging to protect them from light and moisture.
- Child safety: Store the medication in a secure location out of the sight and reach of children and adolescents.
- Expiry date: Check the expiry date on the packaging before use. The expiry date (EXP) refers to the last day of the stated month. Do not take expired medication.
- Disposal: Do not dispose of unused medication via household waste or down the drain. Return unused or expired tablets to a pharmacy for safe disposal to help protect the environment.
What Does Propavan Contain?
Each Propavan tablet contains 25 mg of propiomazine (as propiomazine maleate) as the active substance, along with inactive ingredients including anhydrous lactose, magnesium stearate, gelatin, talc, and potato starch.
Active substance: Propiomazine 25 mg (as propiomazine maleate). Propiomazine is the pharmacologically active component responsible for the sedative effect.
Inactive ingredients (excipients):
- Anhydrous lactose (116 mg) – filler/diluent
- Magnesium stearate – lubricant
- Gelatin – binder
- Talc – glidant
- Potato starch – disintegrant
- Macrogol 400 – plasticiser (coating)
- Hypromellose – film-forming agent (coating)
- Opaspray – coating agent
- Titanium dioxide (E171) – opacifier/colorant (coating)
Each Propavan tablet contains 116 mg of anhydrous lactose. If you have been told by your doctor that you have an intolerance to certain sugars, contact your healthcare provider before taking this medicine. The lactose content is relatively high, which may be relevant for patients with severe lactose intolerance.
Appearance: Propavan tablets are white to yellowish-white, round, convex, with a score line on one side. The tablet diameter is 9 mm.
Pack sizes: Propavan is available in blister packs of 20, 50, or 100 tablets, unit-dose blisters of 49 × 1 tablets, and plastic jars of 250 tablets (for machine dispensing). Not all pack sizes may be marketed in all countries.
Frequently Asked Questions About Propavan
Propavan (propiomazine) is not classified as a controlled substance and has a lower risk of physical dependence compared to benzodiazepines and Z-drugs such as zopiclone. Its mechanism of action — primarily blocking histamine H1 receptors rather than modulating GABA receptors — means it does not produce the same type of tolerance and withdrawal that characterises benzodiazepine-type drugs. However, psychological dependence can develop with prolonged use, and patients with a history of alcohol, drug, or medication misuse should be closely monitored. Treatment should always be as short as possible.
Propavan reaches its full sleep-inducing effect within 1 to 2 hours after oral administration. For this reason, it is recommended to take the tablet 30 to 60 minutes before you plan to go to sleep. Unlike some faster-acting sleep medications that work within 15 to 30 minutes, Propavan has a more gradual onset but provides sustained sedation throughout the night, reducing the number of nocturnal awakenings. Make sure you have enough time for a full night's sleep after taking Propavan to avoid excessive morning drowsiness.
No, you must not drink alcohol while taking Propavan. The combination of propiomazine and alcohol can lead to extreme drowsiness, profound sedation, and loss of consciousness, which can be life-threatening. Alcohol potentiates the central nervous system depressant effects of Propavan, increasing the risk of respiratory depression, cardiovascular collapse, and death. This warning applies to all forms of alcohol, including beer, wine, and spirits. If you have consumed alcohol, do not take Propavan that evening.
Propavan can be used in elderly patients but requires extra caution. Older adults are more sensitive to the effects of propiomazine, including excessive daytime drowsiness, muscle stiffness, slowed movements, restlessness (akathisia), and impaired balance — all of which increase the risk of falls and fractures. The recommended approach is to start with the lowest effective dose (25 mg), use the medication for the shortest possible duration, and monitor closely for adverse effects. Non-pharmacological approaches such as sleep hygiene education and cognitive behavioural therapy should be considered as first-line treatments for insomnia in elderly patients.
Yes, dry mouth (xerostomia) is a recognised side effect of Propavan, particularly with prolonged use. Chronic dry mouth reduces the protective effect of saliva, which normally helps neutralise acids and wash away food particles, leading to an increased risk of tooth decay (dental caries) and damage to the oral mucosa. To minimise dental complications, brush your teeth carefully with fluoride toothpaste at least twice daily, use sugar-free chewing gum or lozenges to stimulate saliva production, drink water regularly, and visit your dentist for regular check-ups. If dry mouth is persistent and troublesome, discuss this with your healthcare provider.
Propavan (propiomazine) is fundamentally different from benzodiazepines (such as diazepam) and Z-drugs (such as zopiclone) in its mechanism of action. While benzodiazepines and Z-drugs work by enhancing the inhibitory neurotransmitter GABA at the GABA-A receptor, propiomazine is a phenothiazine derivative that produces sedation primarily by blocking histamine H1 receptors in the brain. This different mechanism means that Propavan generally carries a lower risk of physical dependence, tolerance, and withdrawal symptoms compared to benzodiazepine-type drugs. However, propiomazine can cause extrapyramidal side effects (muscle stiffness, restlessness, involuntary movements) due to its weak dopamine D2 receptor antagonism — side effects that do not typically occur with benzodiazepines or Z-drugs. The choice between these medication classes depends on individual patient factors and should be made by a healthcare professional.
References
- European Medicines Agency (EMA). Summary of Product Characteristics: Propiomazine-containing medicinal products. Available at: www.ema.europa.eu. Accessed December 2025.
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. Geneva: WHO; 2023.
- National Institute for Health and Care Excellence (NICE). Clinical guideline [CG191]: Insomnia. Available at: www.nice.org.uk. Updated 2023.
- Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675–700. doi:10.1111/jsr.12594
- Sateia MJ, Buysse DJ, Krystal AD, et al. Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017;13(2):307–349. doi:10.5664/jcsm.6470
- Glass J, Lanctot KL, Herrmann N, et al. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005;331(7526):1169. doi:10.1136/bmj.38623.768588.47
- Buscemi N, Vandermeer B, Friesen C, et al. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22(9):1335–1350. doi:10.1007/s11606-007-0251-z
- Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge University Press; 2021.
- British National Formulary (BNF). Hypnotics and Anxiolytics – Drug Monographs. NICE Evidence Services. Available at: bnf.nice.org.uk. Accessed December 2025.
- CNX Therapeutics Ireland Ltd. Patient Information Leaflet: Propavan 25 mg tablets. Updated August 2024.
Editorial Team
iMedic Medical Editorial Team
Our medical editorial team consists of licensed physicians and pharmacists with specialist knowledge in clinical pharmacology, sleep medicine, and evidence-based practice. All content is developed in accordance with international clinical guidelines.
iMedic Medical Review Board
An independent panel of board-certified physicians who review all content for medical accuracy, completeness, and adherence to current evidence. Reviews follow the GRADE evidence framework and international prescribing guidelines (EMA, BNF, WHO).
This article was last medically reviewed on . Our editorial process ensures regular review and updates in response to new evidence and guideline changes. For more information, see our editorial standards.